Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas
NCT01380028Phase 3Terminated
- Sponsor
- CHU Montpellier
- Start
- Jul 2011
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic subdural hematoma (CSDH) comparing placebo with oral corticosteroids (2 arms). Primary endpoint: Rate of clinical and/or radiological recurrence of subdural hematoma at 6 months. Started Jul 2011; status: terminated.
02
Drugs
prednisone
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT01380028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01380028.